Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies. - He, Yonghan; Khan, Sajid; Huo, Zhiguang; Lv, Dongwen; Zhang, Xuan; Liu, Xingui; Yuan, Yaxia; Hromas, Robert; Xu, Mingjiang; Zheng, Guangrong; Zhou, Daohong (Journal of Hematology & Oncology, 2020)